David W Osborne Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

David W Osborne is Chief Technical Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 268,854 shares of ARQT, which is worth approximately $2.74 Million. The most recent transaction as insider was on Mar 06, 2023, when has been sold 690 shares (Common Stock) at a price of $15.26 per share, resulting in proceeds of $10,529. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 269K

0% 3M change

0% 12M change

Total Value Held $2.74 Million

DAVID W OSBORNE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2023	SELL Open market or private sale	$10,529 $15.26 p/Share	690 Reduced 0.26%	268,854 Common Stock
Mar 02 2023	SELL Open market or private sale	$19,614 $16.17 p/Share	1,213 Reduced 0.47%	254,644 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	14,900 Added 5.24%	269,544 Common Stock
Feb 28 2023	SELL Open market or private sale	$12,806 $16.17 p/Share	792 Reduced 0.31%	255,857 Common Stock
Jul 08 2022	SELL Open market or private sale	$55,826 $25.41 p/Share	2,197 Reduced 0.85%	256,649 Common Stock
Apr 21 2022	SELL Open market or private sale	$44,863 $20.42 p/Share	2,197 Reduced 0.85%	257,229 Common Stock
Mar 07 2022	SELL Open market or private sale	$460 $16.44 p/Share	28 Reduced 0.01%	259,426 Common Stock
Mar 04 2022	SELL Open market or private sale	$13,960 $16.86 p/Share	828 Reduced 0.32%	259,454 Common Stock
Mar 03 2022	BUY Grant, award, or other acquisition	-	13,300 Added 4.86%	260,282 Common Stock
Mar 01 2022	SELL Open market or private sale	$13,756 $17.75 p/Share	775 Reduced 0.31%	246,982 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	9,500 Added 3.71%	246,753 Common Stock
Mar 01 2021	SELL Open market or private sale	$26,965 $34.57 p/Share	780 Reduced 0.33%	237,253 Common Stock
Dec 14 2020	SELL Open market or private sale	$450,000 $30.0 p/Share	15,000 Reduced 5.65%	250,533 Common Stock
Sep 29 2020	SELL Open market or private sale	$450,000 $30.0 p/Share	15,000 Reduced 5.37%	264,279 Common Stock

DWO

David W Osborne

Chief Technical Officer

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account